Cannabis: Clinical Trials

113 trials for Cannabis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

63 completed, 17 recruiting, 12 unknown, 9 active not recruiting. 35 Not applicable, 32 Phase 1, 25 Phase 2, 8 Early Phase 1, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable35Completed 26, Recruiting 4, Unknown 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1
Phase 132Completed 15, Active not recruiting 6, Recruiting 5, Unknown 4, Not yet recruiting 1, Terminated 1
Phase 225Completed 8, Recruiting 6, Suspended 3, Unknown 3, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1
Early Phase 18Completed 6, Recruiting 1, Unknown 1
Phase 35Completed 2, Recruiting 1, Unknown 1, Withdrawn 1
Phase 42Unknown 1, Withdrawn 1

Follow Cannabis: new trials by email Literature Review of Cannabis trials Research Report on Cannabis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Repeated Administration of Cannabis Varying in THC and CBD
Cannabis - Cannabis
Phase 2SuspendedNew York State Psychiatric Institute1002026-10-012026-09-01
Allergenic Risk Assessment of Hemp Seed
blood sample and skin prick tests - Cannabis, Allergens
Not applicableNot yet recruitingUniversity Hospital, Angers352026-09-012026-06-17
A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users
Cannabis, placebo - Cannabis
Phase 1 / Phase 2Not yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)802026-09-012025-12-22
Repeated CBD Administration and Cannabis Outcomes
Cannabidiol, Medium Dose, Cannabidiol, Higher Dose, Active Inhaled Cannabis - Cannabis, Abuse Liability
Early Phase 1RecruitingHannah Harris232026-08-052026-08-12
Developing and Strengthening Cannabis Warnings: Warning Message Testing
Constituents, Cognitive Functioning, Cardiovascular Health - Cannabis, Marijuana Use
Not applicableCompletedUniversity of North Carolina, Chapel Hill17502026-07-312026-10-06
The Pharmacokinetics of a Hemp-Based Topical Product
CBD, THC - Cannabis
Phase 1RecruitingJohns Hopkins University202026-05-262026-09-03
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 4
Cannabis (smoked flower) - Cannabis, Memory
RecruitingL. Cinnamon Bidwell642025-12-102026-07-01
A Virtual Reality Game to Prevent E-cigarette and Cannabis Vaping
Virtual reality videogame intervention for vaping prevention - Cannabis, Vaping
Not applicableCompletedYale University622025-09-262026-02-17
Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
Cannabis, Nicotine, Pax Loose Leaf Vaporizer - THC, Cannabis
Phase 2RecruitingUniversity of California, San Francisco482025-07-012026-01-07
Sex Hormones Impact on Cannabis Response
Cannabis, Knaster Hemp - Cannabis
Not applicableRecruitingMaastricht University212025-06-012026-02-18
Nicotine and Cannabis Vape Labeling Experiment - Spring 2025
Vaping Device Labeling - Vaping, Adolescent
Not applicableCompletedUniversity of Southern California30482025-03-032026-05-22
Reducing Breathlessness With Dronabinol in COPD Patients
Dronabinol 2.5mg Capsule, Placebo - COPD, Breathlessness
Phase 3CompletedVejle Hospital302025-02-262026-10-05
Effect of Cannabis (Marijuana) on Stomach Emptying Before Surgery
Gastric Emptying, Cannabis
WithdrawnThe Guthrie Clinic2024-12-012024-02-14
Use of Cannabis Oil in Fibromyalgia
Use of cannabis oil - Fibromyalgia, Pain Management
Active not recruitingAzienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria652024-10-192025-09-26
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 3
Cannabis (smoked flower) - Cannabis, Memory
CompletedL. Cinnamon Bidwell962024-10-092026-05-12
Cannabis Edibles and Simulated Driving
Cannabis - Placebo Dose (0 mg), Cannabis - Low Dose (2 mg), Cannabis - Medium Dose (10 mg) - Cannabis, Driving Under the Influence
Not applicableCompletedCentre for Addiction and Mental Health522024-10-012025-08-03
Delta-8-THC vs. Delta-9-THC on Simulated Driving Performance
Delta-9-THC, Delta-8-THC, Placebo - Cannabis
Phase 1CompletedJohns Hopkins University302024-07-012026-07-20
Modulation of THC Effects by CBD: a Dose-ranging Study
∆9-tetrahydrocannabinol - Cannabis, THC
Phase 1 / Phase 2RecruitingCentre hospitalier de l'Université de Montréal (CHUM)1002024-06-272025-12-22
Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy
Aurora 1:1 Drops (Indica), Placebo - Opioid Use Disorder, Methadone
Phase 2RecruitingBC Centre on Substance Use242024-05-232025-02-17
Age Differences in the Effects of Cannabis on Simulated Driving
Cannabis, Placebos - Cannabis
Not applicableRecruitingCentre for Addiction and Mental Health1282024-03-272026-03-23

Showing 20 of 113. Sign in to see all of them.

Narrower conditions

Marijuana Abuse (113)  ·  Alcohol Drinking (5)  ·  Marijuana Smoking (5)  ·  Pain (5)  ·  Psychotic Disorders (5)  ·  Neuralgia (4)  ·  Vaping (4)  ·  Agnosia (3)  ·  Behavior, Addictive (3)  ·  HIV Infections (3)  ·  Schizophrenia (3)  ·  Substance-Related Disorders (3)  ·  Tobacco Use (3)  ·  Alcoholism (2)  ·  Anorexia (2)

Broader conditions

Chemically-Induced Disorders (113)  ·  Mental Disorders (111)  ·  Substance-Related Disorders (110)  ·  Behavior (23)  ·  Pathological Conditions, Signs and Symptoms (21)  ·  Nervous System Diseases (19)  ·  Signs and Symptoms (16)  ·  Neurologic Manifestations (13)  ·  Neuromuscular Diseases (7)  ·  Pathologic Processes (7)  ·  Smoking (7)  ·  Central Nervous System Diseases (6)  ·  Drinking Behavior (6)  ·  Musculoskeletal Diseases (6)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (6)

Interventions

nabiximols (35)  ·  Dronabinol (24)  ·  Cannabidiol (9)  ·  Ethanol (4)  ·  THC 5 (3)  ·  Blood Specimen Collection (2)  ·  Exercise (2)  ·  Medical Marijuana (2)  ·  Neuropsychological Tests (2)  ·  Nicotine (2)  ·  Transcranial Magnetic Stimulation (2)  ·  salicylhydroxamic acid (2)  ·  Cannabinoids (1)  ·  Electrocardiography (1)  ·  Functional Status (1)

Sponsors

Yale University (15)  ·  Johns Hopkins University (9)  ·  University of California, San Diego (5)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (4)  ·  New York State Psychiatric Institute (4)  ·  Duke University (3)  ·  Centre for Addiction and Mental Health (2)  ·  Hadassah Medical Organization (2)  ·  Klein Buendel, Inc. (2)  ·  L. Cinnamon Bidwell (2)  ·  Mclean Hospital (2)  ·  Medical University of Silesia (2)  ·  Medical University of South Carolina (2)  ·  Montefiore Medical Center (2)  ·  National Institute on Drug Abuse (NIDA) (2)

Countries

United States (68)  ·  Canada (12)  ·  Denmark (4)  ·  Israel (4)  ·  Netherlands (3)  ·  Poland (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Slovenia (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Ryan Vandrey, PhD (3)  ·  Tory Spindle, PhD (3)  ·  Claudia Campbell, PhD (2)  ·  Deepika E Slawek, MD, MPH, MS (2)  ·  Didier Jutras-Aswad, MD,MS (2)  ·  Nathaniel M Schuster, MD (2)  ·  Bernard Le Foll, MD, PhD (1)  ·  Brook L Henry, PhD (1)  ·  Christina S Meade, PhD (1)  ·  Christine Genest, PhD (1)  ·  Christine Wickens, PhD (1)  ·  Damjan Osredkar, MD, PhD (1)  ·  David Buller, PhD (1)  ·  David Crowley, MD (1)  ·  Deepa Camenga, MD (1)

Results publications

PMID 12648025, PMID 16317825, PMID 17566383, PMID 18728826, PMID 19587829, PMID 19883531, PMID 19896326, PMID 20076976, PMID 21176784, PMID 21869692, PMID 22076835, PMID 23141881, PMID 26019183, PMID 26144593, PMID 26257143, PMID 26883879, PMID 26889769, PMID 27403414, PMID 28642081, PMID 29435591, PMID 30646391, PMID 32070417, PMID 32707476, PMID 33341180, PMID 33823967, PMID 34399137, PMID 34532852, PMID 35032682, PMID 35787693, PMID 36314198, PMID 36642667, PMID 36750134, PMID 38416223, PMID 38832949, PMID 39334053, PMID 39575727, PMID 40040421, PMID 40069983, PMID 40839659, PMID 41469488, PMID 41514385, PMID 41698715, PMID 42454450, PMID 42514343, PMID 42671837

NIH funding

R01DA052431 (3), K23DA050808 (2), K23DA053997 (2), 2019 (1), 2023 (1), K01DA050691 (1), K01DA056692 (1), K24DA048160 (1), P50DA009241 (1), R01AA029711 (1), R01AA031591 (1), R01CA229617 (1), R01DA025051 (1), R01DA038634 (1), R01DA038709 (1)